beta
Trial Radar IA

Mostrando gli studi clinici per Diabete, Diabete mellito che corrispondono al luogo: Escondido.

Posso aiutarti a capire le condizioni di salute, i trattamenti o a trovare studi clinici vicini.
Il nostro strumento di ricerca supporta solo l'inglese. Per la ricerca e la discussione in altre lingue, usa Trial Radar IA sopra o seleziona i filtri per condizione medica e luogo (qui sotto).
44 risultati trovati
 
Patologia
Diabete, Diabete mellito
×
 
Parole chiave
Monitoraggio continuo del glucosio
×
 
Luogo
Escondido
×
 
Sesso
Tutti
×
 
Titolo dello studio
Stato
Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature NCT07386340
In arruolamento
PRECISION Study: Multi-center Study of Performance of a Novel Implanted CGM System Using a Next Generation Transmitter and Algorithm NCT03251079
CompletatoRisultati pubblicati
Effectiveness and Safety Study of the Dexcom G4 Platinum With Modified Algorithm NCT02087995
CompletatoRisultati pubblicati
Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes Mellitus NCT04838392
Non ancora in arruolamento
FreeStyle Libre Continuous Glucose Monitoring System Accuracy Study NCT04464772
Completato
PROMISE Study: An Evaluation of an Implantable Continuous Glucose Sensor up to 180 Days NCT03808376
CompletatoRisultati pubblicati
Evaluation of the Safety and Effectiveness of the Dexcom Continuous Glucose Monitoring (CGM) System NCT04794478
Completato
Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics NCT04436822
CompletatoRisultati pubblicati
SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 Diabetes NCT06719531
Ritirato
Evaluation of the Safety and Effectiveness of the Dexcom Glucose Monitoring (CGM) System NCT04645641
Sconosciuto
Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features NCT05131139
Sconosciuto
Evaluation of the Accuracy of an Implanted Glucose Sensor (PRECISEII) NCT02647905
CompletatoRisultati pubblicati
Effectiveness and Safety of the Dexcom™ G6 Continuous Glucose Monitoring System NCT02880267
Completato
Biolinq Safety and Effectiveness Trial NCT06229743
CompletatoRisultati pubblicati
Evaluation of the Dexcom G6 Continuous Glucose Monitoring System With a Non-Interferent Sensor NCT03087877
Completato
G5® Mobile Continuous Glucose Monitoring System Automated vs. Manual Sensor Applicator NCT02696252
Completato
Effectiveness and Safety Study of the Dexcom G4™ Continuous Glucose Monitoring System NCT01514292
CompletatoRisultati pubblicati
Assessment of Mealtime Bolus Insulin Behavior NCT03368807
CompletatoRisultati pubblicati
Effectiveness and Safety Study of the Next-Generation DexCom™ SEVEN® Continuous Glucose Monitoring System NCT00722241
Completato
Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM (Air3Pilot) NCT07296276
In arruolamento
Effectiveness and Safety of the Dexcom™ G4 Continuous Glucose Monitoring System in Pediatric Subjects With Diabetes Mellitus NCT01667185
Completato
A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range) NCT04605991
CompletatoRisultati pubblicati
Effects of Nasulin Versus Placebo on Blood Glucose Control in Patient Volunteers With Type 2 Diabetes Mellitus (CPEX-011) NCT00850096
CompletatoRisultati pubblicati
A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus NCT02688933
CompletatoRisultati pubblicati
Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System NCT02073058
Completato
Multiple Dose Study to Evaluate the Efficacy, Safety and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus NCT03117998
CompletatoRisultati pubblicati
Performance Evaluation of an Advanced Algorithm With CGM in Adults, Adolescents, and Pediatrics NCT03966911
CompletatoRisultati pubblicati
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec (COMBINE 1) NCT05352815
CompletatoRisultati pubblicati
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM) NCT01848990
CompletatoRisultati pubblicati
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes NCT07228117
In arruolamento
Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2) NCT02414958
CompletatoRisultati pubblicati
A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 1) NCT04460885
CompletatoRisultati pubblicati
A Study of CT-868 in Type 1 Diabetes Mellitus NCT06062069
Completato
Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients NCT02542631
CompletatoRisultati pubblicati
Assess the Efficacy of the Low Glucose Suspend (LGS) Feature in the MiniMed Paradigm® X54 System NCT01148862
CompletatoRisultati pubblicati
A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6) NCT04848480
CompletatoRisultati pubblicati
A Study of LY900014 in Participants With Type 1 Diabetes (PRONTO-T1D) NCT03214367
CompletatoRisultati pubblicati
A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes NCT00838916
CompletatoRisultati pubblicati
A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-2) NCT05362058
CompletatoRisultati pubblicati
Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3) NCT06297603
Attivo, non in arruolamento
Uno Studio di Ricerca per Vedere Quanto Bene CagriSema Rispetto a Semaglutide, Cagrilintide e Placebo Riduce la Glicemia e il Peso Corporeo nelle Persone con Diabete di Tipo 2 Trattate con Metformina Con o Senza un Inibitore SGLT2 (REIMAGINE 2) NCT06065540
Completato
A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight (REDEFINE 2) NCT05394519
Completato
A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin NCT05275400
CompletatoRisultati pubblicati
A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1) NCT05662332
CompletatoRisultati pubblicati